# Su Ann Ho

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/su-ann-ho/

## Facts

| Field | Value |
| --- | --- |
| Citations | 140 |
| Field | Renal cell carcinoma treatment |
| h-index | 5 |
| i10-index | 4 |
| Last Known Institution | Intertek (Canada) |
| OpenAlex ID | https://openalex.org/A5001762890 |
| Works | 11 |

## Researcher papers

- [Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021](https://scholariq.org/papers/consensus-guidelines-for-optimising-antifungal-drug-delivery-and-monitoring-to/)
- [Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study](https://scholariq.org/papers/safety-and-efficacy-of-intravenously-administered-cidofovir-in-adult/)
- [Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring](https://scholariq.org/papers/optimization-of-ganciclovir-use-in-allogeneic-hematopoietic-cell-transplant/)
- [Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation](https://scholariq.org/papers/evidence-supporting-the-use-of-therapeutic-drug-monitoring-of-ganciclovir-in/)
- [In-flight transmission of measles: Time to update the guidelines?](https://scholariq.org/papers/in-flight-transmission-of-measles-time-to-update-the-guidelines/)
- [Costs associated with invasive <i>Scedosporium</i> and <i>Lomentospora prolificans</i> infections: a case-control study](https://scholariq.org/papers/costs-associated-with-invasive-i-scedosporium-i-and-i-lomentospora-prolificans-i/)
- [PCN42 Real-World Effectiveness in Previously Untreated, Advanced/Metastatic Renal Cell Carcinoma – a Systematic Literature Review Update](https://scholariq.org/papers/pcn42-real-world-effectiveness-in-previously-untreated-advanced-metastatic-renal/)
- [PCN21 Efficacy and Safety in Previously Untreated, Advanced/Metastatic Renal Cell Carcinoma – a Systematic Literature Review Update](https://scholariq.org/papers/pcn21-efficacy-and-safety-in-previously-untreated-advanced-metastatic-renal-cell/)
- [PCN301 Reported Utilities for Patients with Previously Untreated Advanced/Metastatic Renal Cell Carcinoma - a Systematic Literature Review Update](https://scholariq.org/papers/pcn301-reported-utilities-for-patients-with-previously-untreated-advanced/)
- [PCN131 Cost-Effectiveness Models and Resource Use/Cost Inputs for Untreated Advanced/Metastatic Renal Cell Carcinoma- A Systematic Literature Review](https://scholariq.org/papers/pcn131-cost-effectiveness-models-and-resource-use-cost-inputs-for-untreated/)
- [Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/blood-lipid-levels-in-response-to-almond-consumption-a-systematic-review-and/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Herpesvirus Infections and Treatments](https://scholariq.org/topics/herpesvirus-infections-and-treatments/)

## Researcher university

- [Intertek (Canada)](https://scholariq.org/institutions/intertek-canada/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.